← ALB News · curated headline

Engineered albumin helps a therapeutic protein last longer and cross mucosal barriers

Phys.org · WORLD · Science · 10/28/2026, 6:00:05 AM

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent injections place a considerable burden on everyday life.

Continue to Phys.org →

You are being forwarded in 6s — stay on this page